Josep Bassaganya-Riera
Directeur Général chez Biotherapeutics, Inc.
Provenance du réseau au premier degré de Josep Bassaganya-Riera
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 10 | |
Nutritional Immunology & Molecular Medicine Laboratory
1
| Non-Profit Organization | 1 | |
Biotherapeutics, Inc.
 Biotherapeutics, Inc. BiotechnologyHealth Technology Biotherapeutics, Inc. operates as a pre-clinical stage company which develops small-molecule drugs to treat inflammation and type 2 diabetes. Its scientific foundation is anchored on informatics and computer modeling-enabled drug development with significant animal pharmacology validation. The company was founded by Josep Bassaganya-Riera in 2008 and is headquartered in Blacksburg, VA.
1
| Holding Company | Biotechnology | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Josep Bassaganya-Riera via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Choate, Hall & Stewart LLP
 Choate, Hall & Stewart LLP Miscellaneous Commercial ServicesCommercial Services Choate, Hall & Stewart LLP provides legal services. It offers services in the areas of private equity, technology, intellectual property, mergers & acquisitions, commercial litigation, and insurance & reinsurance litigation. The company was founded in 1899 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Perceptive Advisors (Private Equity)
 Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors (Private Equity) (Perceptive Advisors) is a private equity subsidiary of Perceptive Advisors LLC founded in 1999 by Joseph Eric Edelman. The firm is headquartered in New York. | Investment Managers | Private Equity Investor Corporate Officer/Principal Private Equity Investor | |
| NUVASIVE, INC. | Medical Specialties | Comptroller/Controller/Auditor Comptroller/Controller/Auditor | |
Xontogeny LLC
 Xontogeny LLC Pharmaceuticals: MajorHealth Technology Xontogeny LLC operates biotech aggregator company. The firm offers entrepreneurs with guidance and operational support in drug and technology development. The company was founded by Christopher Nishan Garabedian and is headquartered in Boston, MA. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Zucara Therapeutics, Inc.
 Zucara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zucara Therapeutics, Inc. develops and manufactures drug therapy for hypoglycemia in type 1 diabetes people. The company is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Polycore Therapeutics, Inc.
 Polycore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Polycore Therapeutics, Inc. is a biopharmaceutical company that develops treatments for patients with neurodegenerative disorders. The company is based in Philadelphia, PA. Polycore Therapeutics was founded by Sandhya Kortagere, Jim Harris. The company is currently conducting preclinical studies for its lead compound, PCT-3012, a novel small molecule for the treatment of Parkinson's motor symptoms and in patients with early- to mid-stage Parkinson's disease. The CEO is Kelly Beck. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of West Florida | College/University | Graduate Degree | |
Kadmon Corp. LLC
 Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Virginia Polytechnic Institute & State University | College/University | Corporate Officer/Principal | |
| Iowa State University | College/University | Doctorate Degree | |
| Universidad Complutense de Madrid | College/University | Undergraduate Degree | |
Memgen, Inc.
 Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | Pharmaceuticals: Major | Director/Board Member | |
| Old Dominion University | College/University | Undergraduate Degree | |
| TRACON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| OREXIGEN THERAPEUTICS, INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
Jefferies LLC
 Jefferies LLC Investment Banks/BrokersFinance Jefferies LLC is a global investment bank and institutional securities firm headquartered in New York City. The firm was founded in 1962 and is a subsidiary of Jefferies Group LLC, ultimately held by Jefferies Financial Group, Inc. (NYSE: JEF). Jefferies provides corporate clients with research and execution services in equity, fixed income, and foreign exchange markets, as well as a full range of investment banking services such as underwriting, mergers and acquisitions, restructuring and recapitalization, and other advisory services, with all businesses operating in the Americas, Europe and Asia. | Investment Banks/Brokers | Corporate Officer/Principal | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director of Finance/CFO | |
| University of Fortaleza | College/University | Undergraduate Degree | |
Cytori Therapeutics, Inc.
 Cytori Therapeutics, Inc. BiotechnologyHealth Technology Cytori Therapeutics, Inc. develops treatments and devices for cell therapy. The private company is based in San Diego, CA. | Biotechnology | Director of Finance/CFO | |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| KADMON HOLDINGS, INC. | Biotechnology | Director of Finance/CFO | |
UBS Investment Bank (US)
 UBS Investment Bank (US) Investment Banks/BrokersFinance UBS Investment Bank provides investment banking and securities brokerage services. Its clients include institutional and corporate clients, intermediaries, governments, and hedge funds. The firm also provides merger and acquisition advisory, private placement, investment research, foreign exchange, equity, and leverage finance advisory services. The firm is headquartered in San Francisco, CA. | Investment Banks/Brokers | Corporate Officer/Principal | |
| ASTRIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Narsee Monjee Institute of Management Studies | College/University | Graduate Degree | |
| Hemwati Nandan Bahuguna Garhwal University | College/University | Undergraduate Degree | |
| NEXIMMUNE, INC. | Pharmaceuticals: Major | General Counsel | |
| State University of New York at Binghamton | College/University | Undergraduate Degree | |
| Boston University School of Law | College/University | Graduate Degree | |
CereVasc, Inc.
 CereVasc, Inc. Medical SpecialtiesHealth Technology CereVasc, Inc. engages in healthcare services. Ito focuses on the development of novel, minimally invasive treatments for patients with neurological diseases. The company was founded by Dan Levangie, Patrick Sullivan, Carl Heilman, and Adel Malek and is headquartered in Auburndale, MA. | Medical Specialties | Director/Board Member | |
| Stony Brook University | College/University | Undergraduate Degree | |
| ARYA SCIENCES ACQUISITION CORP V | Financial Conglomerates | Founder | |
Shanghai Lianbio Development Co., Ltd.
 Shanghai Lianbio Development Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of LianBio, Shanghai Lianbio Development Co., Ltd. is a company that manufactures paradigm-shifting medicines to patients. The company is based in Shanghai, China. The CEO of the Chinese company is Debra Yu. | Pharmaceuticals: Major | Director/Board Member | |
| LIANBIO | Biotechnology | Founder | |
| ARYA SCIENCES ACQUISITION CORP IV | Financial Conglomerates | Founder | |
| PLUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| LYRA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
NiKang Therapeutics, Inc.
 NiKang Therapeutics, Inc. BiotechnologyHealth Technology NiKang Therapeutics, Inc. operates as biotechnology company. It focuses on developing novel small molecule oncology drug discovery. The company was founded by Zhenhai Gao and is headquartered in Wilmington, DE. | Biotechnology | Director/Board Member | |
Rocket Pharmaceuticals Ltd.
 Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rocket Pharmaceuticals Ltd. operates as a biotechnology company which focuses on developing gene therapy treatment for undertreated diseases. The firm’s pipeline includes Fanconi Anemia, Pyruvate Kinase Deficiency, Leukocyte Adhesion Deficiency-1 and Infantile Malignant Osteopetrosis. It also develops an AAV-based therapy program for an undisclosed rare pediatric disease. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chairman | |
| ESPERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Michigan Ross Zell Lurie Institute / Venture Capital/
 Michigan Ross Zell Lurie Institute / Venture Capital/ Investment ManagersFinance Michigan Ross Zell Lurie Institute / Venture Capital/ (Zell Lurie Institute) is a venture capital subsidiary of Zell Lurie Institute for Entrepreneurial Studies Studies founded in 1997 by Samuel Zell, Ann Lurie and Robert H. Lurie. The firm is headquartered in Ann Arbor, Michigan. | Investment Managers | Corporate Officer/Principal | |
Esperance BioVentures LLC
 Esperance BioVentures LLC Investment ManagersFinance Founded in 1998 by Roger Newton and Timothy Mayleben, Esperance BioVentures LLC is a venture capital firm located in Ann Arbor, Michigan | Investment Managers | Founder |
Statistiques
Internationale
| Etats-Unis | 40 |
| Canada | 3 |
| Inde | 3 |
| Espagne | 2 |
| Chine | 2 |
Sectorielle
| Health Technology | 23 |
| Consumer Services | 12 |
| Finance | 10 |
| Commercial Services | 4 |
| Technology Services | 2 |
Opérationnelle
| Director/Board Member | 40 |
| Corporate Officer/Principal | 17 |
| Director of Finance/CFO | 12 |
| Independent Dir/Board Member | 12 |
| Chairman | 10 |
Relations les plus connectées
- Bourse
- Insiders
- Josep Bassaganya-Riera
- Connexions Sociétés
